1 / 43

SAMA EMERGENCY COURSE Assad University hospital Satarday , February 26, 2012

Transfusion Medicine Nabeel Rajeh , M.D. SAMA EMERGENCY COURSE Assad University hospital Satarday , February 26, 2012. Alexander Bogdanov- Blood Transfusion. Whole Blood. 450 ml of donated blood+50 ml of anticoagulant

teo
Download Presentation

SAMA EMERGENCY COURSE Assad University hospital Satarday , February 26, 2012

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Transfusion Medicine NabeelRajeh, M.D. SAMA EMERGENCY COURSE Assad University hospital Satarday , February 26, 2012

  2. Alexander Bogdanov- Blood Transfusion

  3. Whole Blood • 450 ml of donated blood+50 ml of anticoagulant • Significant RBC, Plasma, Protein, platelets, Leukocytes, and stable coagulation factors. • Insignificant labile factors V, VIII, • After 24 h platelets and leukocytes loose viability • Indicated in trauma hypovolemic and actively bleeding patient • No other indications

  4. Packed Red Blood Cells (PRBC) • The most common type of transfusions • 250-350 ml of Red blood cells • Indicated in chronic anemia • Indicated in active bleeding with and without hypovolemia • Not indicated in platelets or leukocytes replacement

  5. Washed RBC • Washing RBC in saline • Removing immunoglobline IgA • Prevent Anaphylaxis and urticarial reaction

  6. Leukocytes-Reduced RBC • Removing 99.9 % of leukocytes from PRBC • Special filters • Indications: • Prevent febrile non-hemolytic reaction • Prevent alloimmunization • Prevent post transfusion purpura

  7. Irradiated RBC • 2500 c Gray gamma irradiation • Prevent post transfusion GVHD • All immune suppressed individuals should receive only irradiated blood products • FFP, and cryoprecipitate need no irradiation

  8. Random-Donor platelets • 50-70 ml volume • Indicated in bleeding patient with low platelets • Indicated in non-bleeding patient with platelets less than 10 000 • Indicated in bleeding patient with platelets function abnormality • Not indicated in none bleeding ITP patient • Contraindicated in TTP, some DIC

  9. HLA matched platelets • Hemapheresis from HLA matched individual donor • Refractoriness to platelets transfusion • HLA alloimmunization • Fever, Sepsis • DIC • Hyperspleenisim • Bleeding • Indicated only in HLA alloimmunization • Low platelets 1h and 24 h post RDP transfusion indicates alloimmunization.

  10. Granulocyte Concentrates • Leukapheresis from single donor • A unit contain 10x 10 granulocytes • Should be infused immediately after collection • Indicated in septic neonates, granulocytes dysfunction, profound neutropenia and sepsis • Granulocyte concentrates transfusion has conflicting trials results

  11. Fresh Frozen Plasma FFP • Separating and freezing plasma within 6 h of phlebotomy • 1ml FFP contain 1unit labile and stable Coagulation factors • Indicated in factors deficiency when no single factor is available • Indicated in liver dysfunction, massive transfusion

  12. Cryoprecipitate • 5-20 ml • 80U VIII, vWF,fibrinogen, some XIII, fibronectin • Indicated in fibrinogen replacement • Not indicated in hemophilia A • Not indicated in vW disease

  13. TRANSFUSION is BAD • IMMUNE-MEDIATED REACTIONS • Acute Hemolytic Transfusion Reactions • Delayed Hemolytic and Serologic Transfusion React • Febrile Nonhemolytic Transfusion Reaction • NONIMMUNOLOGIC REACTIONS • Fluid Overload • Electrolyte Toxicity • Iron Overload • INFECTIOUS COMPLICATIONS

  14. INFECTIOUS COMPLICATIONS • Hepatitis, A, B, C, D, G ………. • HIV, HTLV-I, HTLV-II, ……… • CMV • EBV • Malaria, Syphlis, Trypanosoma, Toxolplasmosis, Bebesiosis, Brucelosis. • Bacteria Gram +ve or Gram -ve

  15. Acute Hemolytic Transfusion Reactions • ABO Incompatible Blood • IgM, ANTI A, OR B Agglutinates transfused RBC • Fever, chills, chest arm and flank pain, dyspnia, hemoglobinuria, oligouria, shock, and DIC • +ve coombs test, and hemolysis lab • Treatment is suportive

  16. Delayed Hemolytic and Serologic Transfusion Reactions • Primery or secondary immunization against RBC alloantibodies • Kell, Duffy, Kidd, RH system antigens • Rapid fall in Hg after transfusion • Most cases subclinical • Occasional fever chills, nausea, hemoglobinurea

  17. Febrile Nonhemolytic Transfusion Reaction • Agglutinating, or cytotoxic antibodies against antigen on transfused granulocyte • Common in multitransfused patient • Complement activation and cytokins release • Chills, fever, rigor, • Hemolytic transfusion reaction should be ruled out • Leukocytes reducing filters in future blood products

  18. Allergic Reactions • Urticaria • Anaphylactic reaction • Alloimmunization • To red cells antigens • Delayed hemolytic transfusions reaction • To platelets antigens • Refractoriness • Neonatal thrombocytopenia • Post transfusion purpura P1-A

  19. Graft-Versus-Host Disease • Live T lymphocytes transfused to immune suppressed patient • Allo-lymphocytes with different HLA recognize self HLA as foreign HLA • Fever, elevated LFT’s, diarrhea, erythema • Cytopenia, • No available therapy • Prevention by irradiation blood products

  20. Post transfusion Purpura • Very serious side effect of transfusion • Most people are positive P1-A1 antigen • Negative patient may develop antigen destroy all platelets • Develop in 5-10 days post transfusion • Plasmapheresis • Washed RBC for future transfusion

  21. Transfusion-Related Acute Lung Injury • Potent leukoagglutinins • Antibody-antigen leading to leak syndrome in lung • Respond quickly to supportive treatment

  22. Emergency Transfusion • What products to use • From where are they to be obtained • To what degree are they to be tested • How will they be transported • How will they be stored • Triage is vital in mass casualty situations, ensuring that scarce resources are used for those with the best chance of recovery. • Patients survive with low hemoglobin levels for considerable periods, • Speedy treatment of hypovolemia is imperative

  23. Sudden increase the demand for blood • May create a sudden massive influx of donors • Restricts or eliminates the ability to collect, test, processor distribute blood • Restricts or prevent the use of the available inventory of blood components (liquid and frozen) • Requires immediate replacement or re-supply of blood from another region/country

  24. Blood Volume Loss Of: • 15 - 30 percent -- should be treated with crystalloids or colloids, not RBCs, in young, healthy patients; • 30 - 40 percent -- requires rapid volume replacement, and RBC transfusion is probably necessary; • >40 percent -- is life-threatening and volume replacement, including RBC transfusion, is required

  25. Hemoglobin and Transfusion • More than 10g/dL transfusion is rarely indicated. • Hemoglobin 6-10 g/dL indications for transfusion should be based on the patient’s risk of inadequate oxygenation from ongoing bleeding and/or high-risk factors. • Hemoglobin < 6 g/dL transfusion is almost always indicated.

  26. Massive transfusion • Transfusion more than50 %of a patient's blood volume in 12 to 24 hours • Hemostatic and metabolic complications • Selection of the appropriate amounts and types of blood components to be administered • Volume status • Tissue oxygenation • Management of bleeding and coagulation abnormalities • Changes in ionized calcium, potassium, and acid-base balance

  27. ALTERNATIVES TO TRANSFUSION • Autologous blood transfusions • Preoperative • Intraoperative • Postoperative blood salvage • Usage of Growth factors • Erythropoietin • G-CSF, GM-CSF • Erythropoietin, IL-11 • Blood substitutes

  28. Thank you Nabeel Rajeh, MD

  29. BLOOD GROUP ANTIGENS AND ANTIBODIES • The foundation of transfusion medicine • No mistake is excused • Compatibility test done on transfused RBC and recipient plasma • Compatibility test for RBC and whole blood • No compatibility test foe platelets, FFP , and cryoprecipitate • Compatibility test detects unexpected RBC alloantibodies • Cross match

  30. BLOOD COMPONENTS • Red blood cells • White blood cells • Platelets • Plasma • Different proteins, Coagulation factors, Albumin

  31. Case # 2 • 60 Y F while taking blood Unit developed 39 fever and rigor • Your next best step is • Immediate discontinuation of transfusion • NSAID or Paracetamol, • Solo-cortef and Phenergan • Call your senior resident • Ignore fever • Further testing

  32. Case # 3 • 16 Y O M with Bleeding ulcer, HG 4.5, BP80/60, HR 140/m. Bright red blood per NG tube. Hx of multiple transfusions • Blood group A +, all 10 U of PRBC were not compatible • You do what of the following • Transfuse Non compatible blood • Cross match 10 more units • Call hematology • Wait until he cardiopulmonary arrest • Call surgery

  33. Case # 4 • 20 Y M came to ER with severe hemolytic anemia G6PD • Hg 2 Gm, Decline any transfusion for religious reason • Your best management • Oxygen • Fluid • Erythropoietin • Transfusion after general anesthesia • Call hematology

  34. How many Unit to transfuse • No magic number • Indication • Diagnosis • Medical plan

  35. ABO ANTIGENS AND ANTIBODIES • The major blood groups of this system are A, B, AB, and O • The genes determine the A and B found on chromosome 9p

  36. RH SYSTEM • Second most important blood group system • On chromosome 1 • 15 percent of people lack this antigen • Exposure of these Rh-ve people to Rh-ve cells, by either transfusion or pregnancy, can result in the production of anti-D alloantibody.

  37. OTHER BLOOD GROUP SYSTEMS AND ALLOANTIBODIES • Other ABO, D, antigen on RBC • Kell, Duffy, Kidd blood group • Not normally present unless immunized by transfusion or pregnancy • Antibody screen • Washing RBC and better selection

  38. PRETRANSFUSION TESTING • Hepatitis B, C, B core • Antibodies for Human T lymphocyte Virus I,II (HTLVI,II) • HIV,I, II

More Related